SCHEMBL25868485

SCHEMBL25868485

CCCOCC(N)(COCCC(=O)OC)COCCC(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.41
LMNA P02545 3/20 0.36
KDM4E B2RXH2 1/20 0.36
CA12 O43570 3/20 0.34
CA14 Q9ULX7 3/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
RECQL P46063 1/20 0.32
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KAT2B Q92831 1/20 0.31
POLB P06746 1/20 0.31
POLA1 P09884 1/20 0.31
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL437769 0.93 TSHR (0.48) TSHRLMNAKDM4ECA12CA14
SCHEMBL13660496 0.89 TSHR (0.41) TSHRLMNAKDM4ECA12CA14
SCHEMBL437778 0.89 TSHR (0.44) TSHRLMNAKDM4ECA12CA14
SCHEMBL12723336 0.86 TSHR (0.48) TSHRLMNAKDM4ECA12CA14
SCHEMBL20429066 0.85 TSHR (0.44) TSHRLMNAKDM4ECA12CA14
SCHEMBL437823 0.84 TSHR (0.40) TSHRLMNAKDM4ECA12CA14
SCHEMBL436742 0.84 TSHR (0.47) TSHRLMNAKDM4ECA12CA14
SCHEMBL10107130 0.84 TSHR (0.43) TSHRLMNAKDM4ECA12CA14
SCHEMBL436743 0.84 TSHR (0.43) TSHRLMNAKDM4ECA12CA14
SCHEMBL445490 0.82 TSHR (0.55) TSHRLMNAKDM4ECA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767301-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2023-09-26 US disclosed
US-20230271994-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS UNIV YALE (US) 2023-08-31 US disclosed
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins UNIV YALE (US) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271994-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS ASGR1, MSR1, LDLR TSHR 478/4885LMNA 2180/4885KDM4E 3430/4885
US-11767301-B2 Bi-functional molecules to degrade circulating proteins MIF, ASGR1, FCGR2A TSHR 943/4885LMNA 3311/4885KDM4E 4546/4885
US-20230233689-A1 Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins ASGR1, LDLR, FCGR2A TSHR 665/4885LMNA 3307/4885KDM4E 4040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.